ProQR Therapeutics N.V. (PRQR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

ProQR Therapeutics N.V.

NASDAQ: PRQR · Real-Time Price · USD
2.11
0.04 (1.93%)
At close: Sep 26, 2025, 3:59 PM
2.14
1.42%
After-hours: Sep 26, 2025, 06:15 PM EDT

ProQR Therapeutics Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
149.41M 118.92M 94.78M 187.52M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 621K 629K
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
2.03M 1.27M 57.24M n/a
Inventory
n/a n/a 6.87K 266.45K
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
153.84M 120.99M 154.46M 191.48M
Property-Plant & Equipment
14.11M 16.9M 16.24M 17.47M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
14.11M 16.9M 16.86M 18.1M
Total Assets
167.96M 137.88M 171.32M 209.58M
Account Payables
16K 1.54M 392K 191K
Deferred Revenue
21.94M 20.57M 5.76M 5.12M
Short-Term Debt
4.58M n/a 2.5M 4.77M
Other Current Liabilities
9.32M 8.82M 9.95M 14.76M
Total Current Liabilities
38.9M 34.2M 21.11M 27.6M
Long-Term Debt
n/a 4.29M 4.27M 39.32M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
40.5M 62.29M 85.1M 68.75M
Total Liabilities
79.4M 96.49M 106.21M 96.35M
Total Debt
17.22M 19.73M 21.97M 60.37M
Book Value
88.56M 41.39M 65.11M 113.23M
Book Value Per Share
1.08 0.51 0.91 1.76
Common Stock
4.31M 3.37M 3.37M 3M
Retained Earnings
-427.16M -400.85M -380.68M -317.77M
Comprehensive Income
27.6M 25.98M 30.26M 30.3M
Shareholders Equity
88.56M 41.39M 65.5M 113.83M
Total Investments
n/a -98.05K 621K 629K